摘要
急性肾损伤(AKI)是由各种病因引起短时间内肾功能快速减退而导致的临床综合征,迁延不愈可进一步发展为慢性肾脏病(CKD)甚至终末期肾病。尽管连续肾脏替代治疗可用于治疗重度AKI,但在很大程度上尚缺乏有效的AKI治疗药物。中医药因其多靶点、多通路的巨大优势,在治疗AKI及相关并发症方面已积累大量理论基础和实践经验。地黄作为临床常用的中药,具有清热凉血、养阴生津之功,其主要活性成分包含梓醇、毛蕊花糖苷、桃叶珊瑚苷等。该研究通过总结近年来地黄活性成分在防治AKI中的相关研究,发现改善炎症、缓解氧化应激、抑制细胞凋亡是地黄抗AKI药理活性的关键切入点,同时地黄活性成分所体现出的抗纤维化作用显示出其具有阻碍CKD进展的潜力。该研究从地黄治疗AKI的作用机制及其抗纤维化两大方面进行综述,为促进AKI新药的研发、推动地黄资源的开发利用及减少AKI向CKD的转变提供科学依据。
Acute kidney injury(AKI)is a clinical syndrome characterized by a rapid decline in renal function over a short period due to various etiologic factors.If left untreated,AKI can progress to chronic kidney disease(CKD)or even end-stage renal disease(ESRD).Although continuous renal replacement therapy(CRRT)can manage severe AKI,effective pharmacological treatments for AKI remain largely unavailable.Chinese medicine,with its multi-target and multi-pathway approaches,has accumulated substantial theoretical and practical knowledge in treating AKI and related complications.Rehmanniae Radix is a commonly used Chinese medicinal,known for its functions in clearing heat,cooling blood,nourishing yin,and promoting fluid production.The primary active ingredients of Rehmanniae Radix include catalpol,acteoside,and aucubin.In this study,we summarized recent research on the effect of the active ingredients of Rehmanniae Radix in preventing and treating AKI.We found that the key mechanisms underlying its anti-AKI effects include amelioration of inflammation,alleviation of oxidative stress,and inhibition of apoptosis.Additionally,the antifibrotic properties of the active ingredients of Rehmanniae Radix suggest its potential in slowing CKD progression.We reviewed the mechanisms of Rehmanniae Radix in treating AKI and its antifibrotic effects to provide a scientific basis for developing new AKI drugs,promoting the utilization of Rehmanniae Radix resources,and reducing the transition from AKI to CKD.
作者
王文茹
梁莹
陈瑶
展婧怡
詹添
闫蕾
刘峰兆
李纪新
余仁欢
WANG Wenru;LIANG Ying;CHEN Yao;ZHAN Jingyi;ZHAN Tian;YAN Lei;LIU Fengzhao;LI Jixin;YU Renhuan(Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091,China;Shandong University of Traditional Chinese Medicine,Jinan 250355,China)
出处
《中国实验方剂学杂志》
CAS
CSCD
北大核心
2024年第21期289-298,共10页
Chinese Journal of Experimental Traditional Medical Formulae
基金
国家自然科学基金面上项目(82174362)
2022年度北京市重点专科项目(BJZKBC0006)
中国中医科学院科技创新工程项目(CI2021A01208)
中国中医科学院西苑医院能力提升项目(XYZX0201-20)。
关键词
地黄
急性肾损伤
纤维化
作用机制
研究进展
Rehmanniae Radix
acute kidney injury
fibrosis
mechanism of action
research progress